戻る Agenda
Joint Session 1: CTIS/ CTR: 1 year into its full application
Session Chair(s)
Ruediger Pankow, DrSc
Clinical Trial Regulatory Consultant | CTIS SME
Independent Consultant, Germany
Scott Feiner
Senior Manager, Trial Disclosure
AbbVie, United States
Speaker(s)
Industry Perspective
Gerhard Schlueter, DrSc, MSc
Bayer AG, Germany
Head of Strategic and Technical Operations, Regulatory Affairs
NCAs Perspective
Maria Elgaard Sørensen
Danish Medicines Agency, Denmark
Special advisor
Ethics Perspective
Guido Grass, MD
University of Cologne, Germany
Ethic Commission
Panel discussion with Q&A with additional participation of:
Laura Pioppo, MSc
European Medicines Agency, Netherlands
ACT EU Programme Manager